Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001654954-24-013972
Filing Date
2024-11-08
Accepted
2024-11-08 09:10:40
Documents
1
Period of Report
2024-11-08

Document Format Files

Seq Description Document Type Size
1 TEZSPIRE NASAL POLYPS TRIAL MET PRIMARY ENDPOINTS a5104l.htm 6-K 59060
  Complete submission text file 0001654954-24-013972.txt   60267
Mailing Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA
Business Address 1 FRANCIS CRICK AVENUE CAMBRIDGE BIOMEDICAL CAMPUS CAMBRIDGE X0 CB2 0AA 011 44 20 7304 5000
ASTRAZENECA PLC (Filer) CIK: 0000901832 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-11960 | Film No.: 241438199
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)